Archive

Archive for the ‘Phase II trial clearence’ Category

Myoblast Program Update, Advanced Cell Technology (ACTC.OB)

September 29th, 2010 No comments

ACT or ACTC.OB provided an update today on the status of its myoblast program. Read more…